IDEXX Laboratories And Its Real Value
Portfolio Pulse from
IDEXX Laboratories has demonstrated a long-term annualized growth of 24.75%, despite a recent 20% loss. The company's innovative products and international expansion are expected to drive an 11.54% annual EPS growth over the next five years, offsetting declining US clinical visits.
February 10, 2025 | 4:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
IDEXX Laboratories has a strong long-term growth record, with a 24.75% annualized growth rate. Despite a 20% loss this year, the company is poised for an 11.54% annual EPS growth over the next five years due to innovative products and international expansion.
IDEXX Laboratories has a proven track record of growth, and despite recent losses, its focus on innovation and international markets is expected to drive future earnings growth. This positive outlook is likely to have a favorable impact on its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100